The trial is continuing and will collaborate with government bodies to ensure effective and quick distribution once the drug is approved as a prophylactic treatment against COVID-19, said Dr J. Hareendran Nair, Founder and Managing Director
The trial is continuing and will collaborate with government bodies to ensure effective and quick distribution once the drug is approved as a prophylactic treatment against COVID-19, said Dr J. Hareendran Nair, Founder and Managing Director